AXSM
AXSM
NASDAQ · Pharmaceuticals

Axsome Therapeutics Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$158.75
+1.91 (+1.22%)
As of Mar 24, 9:46 PM ET ·
Analyst Consensus
Strong Buy
26
Analysts
High
Coverage
Buy 24 92%
Hold 2 8%
Sell 0 0%
Price Target
Analyst Price Target -58.4% upside
Low Target $47.60
Average Target $66.03
High Target $88.20
Current Price $158.75
Current
$158.75
Target
$66.03
$47.60 $66.03 avg $88.20
Scenario Analysis
Bear Case
$47.60
-70.0%
Low target
Base Case
$66.03
-58.4%
Avg target
Bull Case
$88.20
+-44.4%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$191.50
-17.1% from high
52-Week Low
$86.99
+82.5% from low
50-Day SMA
$171.07
-7.2% vs SMA
200-Day SMA
$131.37
+20.8% vs SMA
RSI (14)
51.8
Neutral
Target vs 52W High
$66.03
-65.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +47.3%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +27.3%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +36.9%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +25.7%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +204.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +81.0%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -20.4%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +819.3%